Cargando…

3080 Ensuring Quality in Investigator-Initiated Clinical Trials through Monitoring Concepts Training

OBJECTIVES/SPECIFIC AIMS: Because clinical trial results are instrumental in the approval of a new drug or changes to the practice of medicine, ensuring the accuracy and validity of collected data is critical in the clinical trial process. This function, routinely carried out by clinical trial monit...

Descripción completa

Detalles Bibliográficos
Autores principales:	Spinrad, Amelia, Pire-Smerkanich, Nancy, Pacifici, Eunjoo, Uniyal, Apurva, Xie, Annie, Ly, Annie, Chandramohan, Advaita
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Cambridge University Press 2019
Materias:	Regulatory Science & Translational Methods
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6799435/ http://dx.doi.org/10.1017/cts.2019.267

Ejemplares similares

3570 The Regulatory Landscape of Products to Treat Opioid Overdose
por: Singh, Pooja, et al.
Publicado: (2019)

4349 Survey of Regulatory Reforms to Address Comprehension of Clinical Trial Results
por: Kirkland, Matthieu, et al.
Publicado: (2020)

4500 Providing a System for Practical Monitoring Training for Clinical Trials within Academic Institutions
por: Chandramohan, Advaita, et al.
Publicado: (2020)

3567 An Analysis of Current Trends in Inclusion of Historically Underrepresented Populations in Clinical Trials: Women and Geriatrics
por: Chen, Jacqueline, et al.
Publicado: (2019)

4505 Implementation of Real-World Data and Real-World Evidence in Clinical Studies
por: Pham, Jessica, et al.
Publicado: (2020)

391 An Investigation on the Activity of Repurposing Already Marketed Drugs for New Indications from 2015 to 2021.
por: Wu, Wenchao, et al.
Publicado: (2023)

394 Examining the Landscape of Clinical Trials Targeting Alcohol or Opioid Use Among Homeless Individuals
por: Baltazar, Bruno, et al.
Publicado: (2023)

3202 Columbia University’s Personalized IRB Liaison Service: Evaluation over its initial 2.5 years
por: Green, Nancy, et al.
Publicado: (2019)

95347 Examining the Impact of the BPCA: Promoting Pediatric Inclusion in Clinical Trials and Pediatric-Specific Drug Information
por: Ly, Annie, et al.
Publicado: (2021)

4339 Exploring Physician Investigator Clinical Trials Training and Quality Management Systems and its Implementation in Medical School Curriculums
por: Kaur, Sukhmani, et al.
Publicado: (2020)

Principles of dose-setting in toxicology studies: the importance of kinetics for ensuring human safety
por: Borgert, C. J., et al.
Publicado: (2021)

4381 Examination of FDA Pediatric Regulations: Inclusion of Pediatric Populations in Clinical Trials, 2016 - 2018
por: Ly, Annie, et al.
Publicado: (2020)

3076 Findings from the first year of California’s Workplace Violence Prevention in Healthcare standard (Title 8, Section 3342)
por: Odes, Rachel, et al.
Publicado: (2019)

3523 Innovative Approaches to Clinical Research on Placebo Effects: A Regulatory Science Perspective
por: Uweh, Kimberly
Publicado: (2019)

Drug Lag and Key Regulatory Barriers in the Emerging Markets
por: Wileman, Harriet, et al.
Publicado: (2010)

Regulations and guidelines governing stem cell based products: Clinical considerations
por: George, Bobby
Publicado: (2011)

Regulatory Considerations for Biosimilars
por: Nellore, Ranjani
Publicado: (2010)

Registration of Medical Devices
por: George, Bobby
Publicado: (2010)

Implications of ICH-E5: Assessment of drug's sensitivity to ethnic factors and necessity of a bridging study for global drug development
por: Gupta, Sandeep Kumar
Publicado: (2011)

Regulatory requirements for marketing fixed dose combinations
por: Jayasheel, B. G.
Publicado: (2010)

Injury and death in clinical trials and compensation: Rule 122 DAB
por: Ghooi, Ravindra. B.
Publicado: (2013)

Key points of technical review for the registration of SARS-CoV-2 antigen/antibody tests
por: Li, Hongran, et al.
Publicado: (2021)

China NMPA perspective on clinical evaluation of SARS-CoV-2 antibody test reagents in the process of emergency approval
por: Lv, Yunfeng, et al.
Publicado: (2020)

Key points of technical review for the registration of SARS-CoV-2 nucleic acid tests in China
por: Li, Hongran, et al.
Publicado: (2021)

China's NMPA perspective on the clinical performance of SARS-CoV-2 antigen test reagents
por: Lv, Yunfeng, et al.
Publicado: (2022)

Predicting in vivo effect levels for repeat-dose systemic toxicity using chemical, biological, kinetic and study covariates
por: Truong, Lisa, et al.
Publicado: (2017)

A new conceptional model for deriving average dermal absorption estimates from studies with multiple tested concentrations for non-dietary risk assessment of pesticides
por: Kluxen, Felix M., et al.
Publicado: (2022)

Oral nicotine pouches with an aftertaste? Part 1: screening and initial toxicological assessment of flavorings and other ingredients
por: Mallock-Ohnesorg, Nadja, et al.
Publicado: (2023)

Advancing a Framework for Regulatory Use of Real-World Evidence: When Real Is Reliable
por: Dreyer, Nancy A.
Publicado: (2018)

392 Basic Researcher Interviews to iDentify Gaps to Enabling Translation (BRIDGE Translation)
por: Thepmankorn, Parisorn, et al.
Publicado: (2023)

A study on ensuring the quality and safety of pharmaceuticals and medical devices derived from the processing of human embryonic stem cells()
por: Hayakawa, Takao, et al.
Publicado: (2015)

Societal perspective on access to publicly subsidised medicines: A cross sectional survey of 3080 adults in Australia
por: Chim, Lesley, et al.
Publicado: (2017)

A study on ensuring the quality and safety of pharmaceuticals and medical devices derived from the processing of autologous human somatic stem cells()
por: Hayakawa, Takao, et al.
Publicado: (2015)

A study on ensuring the quality and safety of pharmaceuticals and medical devices derived from the processing of allogeneic human somatic stem cells()
por: Hayakawa, Takao, et al.
Publicado: (2015)

A study on ensuring the quality and safety of pharmaceuticals and medical devices derived from processing of autologous human induced pluripotent stem(-like) cells()
por: Hayakawa, Takao, et al.
Publicado: (2015)

A study on ensuring the quality and safety of pharmaceuticals and medical devices derived from processing of allogeneic human induced pluripotent stem(-Like) cells()
por: Hayakawa, Takao, et al.
Publicado: (2015)

Screening of chemicals for human bioaccumulative potential with a physiologically based toxicokinetic model
por: Tonnelier, Arnaud, et al.
Publicado: (2011)

Indian Regulatory Update: Jan-May 2014
por: Suvarnapathaki, Kedar
Publicado: (2014)

Sensory irritation as a basis for setting occupational exposure limits
por: Brüning, Thomas, et al.
Publicado: (2014)

Indian Regulatory Update: June-August 2014
por: Suvarnapathaki, Kedar
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_otib3cgbdfdguhqqnvksndejch